Wendy Vogel, NP
Oncology · Lawrenceville, NJNPI 1497748362
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,239 of the $2,756 with a category attached, or 81.2%. It is spread thinly across 20 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,226 and has fallen 93.6% since, to $78 in 2025.
Across 41 payments — averaging $67.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$481
- Johnson & Johnson$381
- Lilly USA, LLC$348
- AstraZeneca$241
- Janssen Scientific Affairs, LLC$168
- Ipsen Biopharmaceuticals, Inc$157
- plus $980 from 14 others
What the payments were for
- Speaking & faculty fees$1495%
- Travel & lodging$923%
- Food & beverage$2,23981%
- Education$27610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 7 | $481 |
| Johnson & Johnson | 3 | $381 |
| Lilly USA, LLC | 5 | $348 |
| AstraZeneca | 3 | $241 |
| Janssen Scientific Affairs, LLC | 3 | $168 |
| Ipsen Biopharmaceuticals, Inc | 3 | $157 |
| Amgen | 1 | $125 |
| Seagen Inc. | 2 | $124 |
| Epizyme, Inc. | 2 | $112 |
| Gilead | 1 | $100 |
| Novocure Inc. | 1 | $81 |
| Novartis | 2 | $78 |
| Incyte Corporation | 1 | $76 |
| Puma Biotechnology, Inc. | 1 | $67 |
| AbbVie | 1 | $60 |
| Daiichi Sankyo Inc. | 1 | $56 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Bristol Myers Squibb | 1 | $22 |
| Sanofi | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,756 in reported general payments places this provider in the 85th percentile of 23 oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other oncology in Lawrenceville
- Ann McNeillNeptune$372K
- Susan WilsonMarmora$10K
- Carol BlecherElizabeth$6K
- Deborah SmithRiverdale$2K
- Michelyne GavinCliffside Park$2K
- Amber DelecceSewell$1K
- Jacquelynn WhiteCamden$908
- Mary KellyBerkeley Heights$799
- Dina EspositoWest Orange$620
- Carol BoyerBerkeley Heights$482
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.